Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
Biorxiv : the Preprint Server for Biology
|
March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.
Clinical and Vaccine Immunology : CVI
|
March 17, 2017
Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission
Qihua Fan, Cody S Nelson, Kristy M Bialas, et al.
Journal of Virology
|
September 8, 2021
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern <i>In Vitro</i> and <i>In Vivo</i>
Kevin Chiem, Desarey Morales Vasquez, Jesus A Silvas, et al.
Plos Pathogens
|
July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.
The Journal of Infectious Diseases
|
March 23, 2026
Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development
Teeba Jihad, Xiaoyuan S Chi, Zhiqing He, et al.
Npj Viruses
|
November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Cell Reports. Medicine
|
March 2, 2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Michael S Piepenbrink, Jun-Gyu Park, Fatai S Oladunni, et al.
Biorxiv : the Preprint Server for Biology
|
May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Journal of Clinical Immunology
|
February 13, 2014
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation
Dhaarini Murugan, Michael H Albert, Jörg Langemeier, et al.
JCI Insight
|
July 7, 2017
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys
Cody S Nelson, Diana Vera Cruz, Dollnovan Tran, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
Biorxiv : the Preprint Server for Biology
|
March 16, 2022
Potent universal-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S Piepenbrink, Jun-Gyu Park, Ashlesha Desphande, et al.
Clinical and Vaccine Immunology : CVI
|
March 17, 2017
Plasmablast Response to Primary Rhesus Cytomegalovirus (CMV) Infection in a Monkey Model of Congenital CMV Transmission
Qihua Fan, Cody S Nelson, Kristy M Bialas, et al.
Journal of Virology
|
September 8, 2021
A Bifluorescent-Based Assay for the Identification of Neutralizing Antibodies against SARS-CoV-2 Variants of Concern <i>In Vitro</i> and <i>In Vivo</i>
Kevin Chiem, Desarey Morales Vasquez, Jesus A Silvas, et al.
Plos Pathogens
|
July 21, 2022
Potent universal beta-coronavirus therapeutic activity mediated by direct respiratory administration of a Spike S2 domain-specific human neutralizing monoclonal antibody
Michael S Piepenbrink, Jun-Gyu Park, Ashlesha Deshpande, et al.
The Journal of Infectious Diseases
|
March 23, 2026
Establishment of a Neonatal Natural Transmission Model for CMV Vaccine Development
Teeba Jihad, Xiaoyuan S Chi, Zhiqing He, et al.
Npj Viruses
|
November 18, 2024
Potent neutralization by a RBD antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Cell Reports. Medicine
|
March 2, 2021
Therapeutic activity of an inhaled potent SARS-CoV-2 neutralizing human monoclonal antibody in hamsters
Michael S Piepenbrink, Jun-Gyu Park, Fatai S Oladunni, et al.
Biorxiv : the Preprint Server for Biology
|
May 15, 2024
Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
Michael S Piepenbrink, Ahmed Magdy Khalil, Ana Chang, et al.
Journal of Clinical Immunology
|
February 13, 2014
Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation
Dhaarini Murugan, Michael H Albert, Jörg Langemeier, et al.
JCI Insight
|
July 7, 2017
Preexisting antibodies can protect against congenital cytomegalovirus infection in monkeys
Cody S Nelson, Diana Vera Cruz, Dollnovan Tran, et al.
Page
of 9